Literature DB >> 31469792

Triphasic Pulses in Cochlear Implant Patients With Facial Nerve Stimulation.

Katharina Braun1, Kevin Walker2, Werner Sürth2, Hubert Löwenheim1, Anke Tropitzsch1.   

Abstract

OBJECTIVE: Evaluation of triphasic pulse stimulation in comparison to the traditional biphasic pulse stimulation in cochlear implant (CI) patients with unintended facial nerve costimulation. STUDY
DESIGN: Retrospective case review.
SETTING: Cochlear Implant Center of a University Department of Otolaryngology, Head and Neck Surgery. PATIENTS: Fifteen CI patients (MED-EL, Innsbruck, Austria) received a triphasic fitting map instead of a biphasic fitting map due to a previous diagnosis of facial nerve stimulation or stimulus induced pain during the years 2014 to 2017. INTERVENTION(S): Application of a triphasic stimulation strategy. MAIN OUTCOME MEASURE(S): Reduction of facial nerve costimulation and speech understanding. Biphasic and triphasic fitting maps were compared to accurately assess the effects of the switch, and hearing tests (monosyllables and sentences in noise tests) were analyzed.
RESULTS: Triphasic pulse stimulation showed a significant reduction of unintended side effects and resulted in an observed improved quality of life in most cases. Although there was no significant change in the understanding of speech with CI in all test situations, in many cases, improvement was observed.
CONCLUSIONS: Triphasic pulse stimulation had a beneficial effect for CI patients with severe, unintended costimulation and should be considered a valuable tool during CI fitting.

Entities:  

Mesh:

Year:  2019        PMID: 31469792     DOI: 10.1097/MAO.0000000000002398

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  1 in total

1.  Management of Severe Facial Nerve Cross Stimulation by Cochlear Implant Replacement to Change Pulse Shape and Grounding Configuration: A Case-series.

Authors:  Susan T Eitutis; Robert P Carlyon; Yu Chuen Tam; Marina Salorio-Corbetto; Zebunnisa Vanat; Karen Tebbutt; Rhian Bardsley; Harry R F Powell; Shibasis Chowdhury; James R Tysome; Manohar L Bance
Journal:  Otol Neurotol       Date:  2022-04-01       Impact factor: 2.311

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.